What should be included in a clinical progress admission note for an adult patient with a history of diabetes or hypertension at a hospital on a given date?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Progress Admission Note Template for Adult Patient with Diabetes/Hypertension

A comprehensive admission note for an adult patient with diabetes or hypertension should clearly document the diabetes type in the medical record, obtain an A1C if not performed in the prior 3 months, and establish a structured insulin regimen that avoids sliding scale insulin as monotherapy. 1

Patient Identification and Chief Complaint

  • Document patient name, medical record number, date of birth, admission date, and location 1
  • State primary reason for admission with brief description of presenting symptoms 1

History of Present Illness

  • Diabetes-specific elements: Document characteristics at onset (age, symptoms), review of previous treatment regimens and response, frequency/cause/severity of past hospitalizations related to diabetes 1
  • Hypoglycemia history: Assess awareness, frequency, causes, and timing of episodes 1
  • Recent glycemic control: Changes in blood glucose patterns, medication adherence, and any precipitating factors for current admission 1
  • Hypertension history: Duration, previous blood pressure readings, medication compliance, and any hypertensive complications 2

Past Medical History

  • Clearly identify diabetes type (type 1 or type 2) in the medical record 1
  • Document common comorbidities: obesity, obstructive sleep apnea, nonalcoholic fatty liver disease 1
  • History of high blood pressure or abnormal lipids 1
  • Macrovascular complications: Coronary artery disease, myocardial infarction, stroke, congestive heart failure, peripheral vascular disease 2
  • Microvascular complications: Retinopathy, nephropathy, neuropathy 1, 2
  • Presence of hemoglobinopathies or anemias 1

Medications

  • Current medication regimen with doses and frequencies 1
  • Medication-taking behavior and adherence patterns 1
  • Medication intolerance or side effects 1
  • Complementary and alternative medicine use 1

Social History

  • Social determinants of health: Food security, housing stability, transportation access, financial security, community safety 1
  • Identify existing social supports and surrogate decision maker 1
  • Tobacco, alcohol, and substance use 1
  • Physical activity and sleep behaviors 1
  • Eating patterns and weight history 1

Family History

  • Family history of diabetes in first-degree relatives 1
  • Family history of autoimmune disorders 1
  • Family history of cardiovascular disease 2

Review of Systems

  • Screen for depression, anxiety, and disordered eating 1
  • Last dental visit and last dilated eye examination 1

Physical Examination

  • Vital signs: Height, weight, BMI, blood pressure (including orthostatic measurements when indicated) 1
  • Fundoscopic examination (or document referral to eye specialist) 1
  • Thyroid palpation 1
  • Skin examination: Acanthosis nigricans, insulin injection or insertion sites, lipodystrophy 1
  • Comprehensive foot examination: Visual inspection for skin integrity, callous formation, foot deformity or ulcer, toenails; screen for peripheral arterial disease with pedal pulses (refer for ankle-brachial index if diminished); determination of temperature, vibration or pinprick sensation, and 10-g monofilament exam 1

Laboratory and Diagnostic Studies on Admission

  • A1C: Perform on all patients with diabetes or hyperglycemia (blood glucose >140 mg/dL) if not performed in prior 3 months 1
  • Basic metabolic panel to assess renal function and electrolytes 1
  • Complete blood count 1
  • Lipid panel if not recently obtained 1
  • Urinalysis 1
  • Consider troponin levels given high prevalence of coronary artery disease in patients with diabetes and hypertension 1

Assessment and Plan

Diabetes Management

  • Avoid sliding scale insulin as monotherapy - this practice is strongly discouraged 1

For noncritically ill patients:

  • Target premeal blood glucose <140 mg/dL with random blood glucose <180 mg/dL 1
  • For patients with poor oral intake or NPO status: Implement basal plus correction insulin regimen 1
  • For patients with good nutritional intake: Implement insulin regimen with basal, nutritional, and correction components 1
  • Use validated written or computerized insulin protocols that allow predefined adjustments based on glycemic fluctuations 1

For critically ill patients:

  • Initiate insulin therapy for persistent hyperglycemia at threshold ≤180 mg/dL 1
  • Target glucose range of 140-180 mg/dL for majority of critically ill patients 1
  • Use intravenous insulin protocol with demonstrated efficacy and safety 1

Hypoglycemia Prevention

  • Establish hypoglycemia management protocol and prevention plan for this patient 1
  • Document any hypoglycemic episodes in medical record 1

Hypertension Management

  • Continue oral antihypertensive therapy for most patients, especially those with concomitant hypertension 1
  • Consider reduction or temporary discontinuation of ACE inhibitors, ARBs, and/or aldosterone antagonists only if worsening azotemia develops 1
  • Monitor blood pressure regularly during hospitalization 1

Vaccination Status

  • Review vaccination history and provide routinely recommended vaccinations according to age-appropriate recommendations 1

Discharge Planning

  • Begin discharge planning at admission with clear diabetes management instructions to be provided at discharge 1
  • For patients with A1C <7.5-8%: Consider discharge on prehospitalization treatment regimen 1
  • For patients with A1C 8-10%: Consider discharge on oral agents plus basal insulin at 50% of hospital basal dose 1
  • For patients with A1C >10%: Discharge on basal-bolus regimen or combination of preadmission oral agents plus 80% of hospital basal insulin dose 1
  • Arrange diabetes self-management education including medication administration, glucose monitoring, and hypoglycemia recognition and treatment 1

Follow-up

  • Document follow-up appointments with primary care physician and endocrinology if indicated 1
  • Ensure appropriate testing and care documented at discharge for patients with new hyperglycemia diagnosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection.

Journal of clinical hypertension (Greenwich, Conn.), 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.